
Global Transgenes Limited
Develops and commercializes transgenic technologies for cotton and other plants.
Develops and commercializes transgenic technologies for cotton and other plants.
Global Transgenes Limited (GTL) is a Public Limited Indian Non-Government Company incorporated in India on 12 January 2000 and has a history of 25 years and three months. Its registered office is in Aurangabad, Maharashtra, India.
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹2.65 Cr.
Shrirang Agrawal, Satish Raina, Sweta Kagliwal, and One other member serve as directors at the Company.
Aurangabad, Maharashtra, India
+91-XXXXXXXXXX
U73100MH2000PLC123602
123602
Public Limited Indian Non-Government Company
12 Jan 2000
30 Sep 2023
31 Mar 2023
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shrirang Agrawal ![]() | Director | 31-Dec-2006 | Current |
Satish Raina ![]() | Director | 31-Dec-2006 | Current |
Sweta Kagliwal ![]() | Director | 25-Mar-2019 | Current |
Jeevanlata Kagliwal ![]() | Director | 25-Mar-2019 | Current |
Global Transgenes Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 12.58% increase in profit. The company's net worth dipped by a decrease of 0.17%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Global Transgenes had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Shrirang Agrawal is a mutual person
Jeevanlata Kagliwal is a mutual person
Sweta Kagliwal and Jeevanlata Kagliwal are mutual person
Shrirang Agrawal and Sweta Kagliwal are mutual person
Jeevanlata Kagliwal is a mutual person
Sweta Kagliwal and Jeevanlata Kagliwal are mutual person
₹2.65 Cr
₹0
Date | Lender | Amount | Status |
---|---|---|---|
09 Jun 2011 | Department Of Biotechnology | ₹2.65 Cr | Open |
Global Transgenes has a workforce of 9 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Global Transgenes, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Global Transgenes's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Global Transgenes Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Global Transgenes Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
Sweta Akash Kagliwal was appointed as a Director was appointed as a Director on 25 Mar 2019 & has been associated with this company since 6 years 1 month .
Jeevanlata Nandkishor Kagliwal was appointed as a Director was appointed as a Director on 25 Mar 2019 & has been associated with this company since 6 years 1 month .
A charge with Department Of Biotechnology amounted to Rs. 2.65 Cr with Charge ID 10292996 was registered on 09 Jun 2011.
Shrirang Shrikishan Agrawal was appointed as a Director was appointed as a Director on 31 Dec 2006 & has been associated with this company since 18 years 4 months .
Global Transgenes Limited was incorporated on 12 Jan 2000.
The authorized share capital of Global Transgenes Limited is ₹ 1.00 Cr and paid-up capital is ₹ 1.00 Cr.
Currently 4 directors are associated with Global Transgenes Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Global Transgenes Limited is Nath House Road India, Aurangabad, Maharashtra, 431005.
The corporate identification number (CIN) of Global Transgenes Limited is U73100MH2000PLC123602 and the company number is 123602 as per Ministry of Corporate Affairs (MCA).
As Per 2023 financial reports, 9 employees are currently employed by Global Transgenes Limited.
The financial reports for the fiscal year 2023 indicates that The net worth of Global Transgenes Limited has experienced an downturn of -0.17%.
As per the financial statements for fiscal Year 2023, The total open charges for Global Transgenes Limited amount to ₹ 2.65 Cr.
The most recent Balance Sheet for Global Transgenes Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
NK
AK